journal article·2019-03-13

Glaucoma Drainage Device Coated with Mitomycin C Loaded Opal Shale Microparticles to Inhibit Bleb Fibrosis

Aimeng Dong, Liang Han, Zhengbo Shao, Pan Fan, Xinrong Zhou, Huiping Yuan

ACS Applied Materials & Interfaces· Volume 11· Issue 10
Publisher page

Abstract

Excessive fibrosis is the topmost factor for the defeat of surgical glaucoma drainage device (GDD) implantation. Adjuvant drug approaches are promising to help reduce the scar formation and excessive fibrosis. Opal shale (OS), as a natural state and noncrystalline silica substance with poriferous nature and strong adsorbability, is highly likely to undertake drug loading and delivery. Here, we employed OS microparticles (MPs) by ultrasound and centrifugation and presented an innovative and improved GDD coated with OS MPs, which were loaded with mitomycin C (MMC). MMC-loaded OS MPs were physically absorbed on the Ahmed glaucoma valve surface through OS' adsorbability. About 5.51 μg of MMC was loaded on the modified Ahmed glaucoma valve and can be released for 18 days in vitro. MMC-loaded OS MPs inhibited fibroblast proliferation and showed low toxicity to primary Tenon's fibroblasts. The ameliorated drainage device was well tolerated and effective in reducing the fibrous reaction in vivo. Hence, our study constructed an improved Ahmed glaucoma valve using OS MPs without disturbing aqueous humor drainage pattern over the valve surface. The modified Ahmed glaucoma valve successfully alleviated scar tissue formation after GDD implantation surgery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Glaucoma and retinal disorders · Proteoglycans and glycosaminoglycans research · Retinal Diseases and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Ophthalmology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150081, P. R. China

The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province 150081, P. R. China

Department of Pharmaceutics, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, P. R. China

Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, P. R. China

Funding

National Natural Science Foundation of China · Natural Science Foundation for Colleges and Universities in Jiangsu Province of China

References (59)

Show source-provided references
1. 10.1016/S0140-6736(17)31469-110.1016/S0140-6736(17)31469-1 ↗
2. 10.1016/j.ajo.2011.10.02410.1016/j.ajo.2011.10.024 ↗
3. 10.1136/bjophthalmol-2017-31027610.1136/bjophthalmol-2017-310276 ↗
4. 10.1016/j.ophtha.2007.10.03410.1016/j.ophtha.2007.10.034 ↗
5. 10.1016/j.survophthal.2004.10.00610.1016/j.survophthal.2004.10.006 ↗
6. 10.1097/00061198-200402000-0000810.1097/00061198-200402000-00008 ↗
7. 10.1016/j.ophtha.2006.01.04910.1016/j.ophtha.2006.01.049 ↗
8. 10.3980/j.issn.2222-3959.2012.01.2210.3980/j.issn.2222-3959.2012.01.22 ↗
9. Dahlmann A. H. · Ophthalmology clinics of North America · 2005 · 18 · 539
10. 10.1016/S0039-6257(03)00038-910.1016/S0039-6257(03)00038-9 ↗
11. 10.1002/14651858.CD006259.pub210.1002/14651858.CD006259.pub2 ↗
12. 10.5867/medwave.2018.01.713810.5867/medwave.2018.01.7138 ↗
13. 10.1016/j.ejps.2012.02.02310.1016/j.ejps.2012.02.023 ↗
14. 10.1371/journal.pone.010063210.1371/journal.pone.0100632 ↗
15. 10.1001/archophthalmol.2009.1910.1001/archophthalmol.2009.19 ↗
16. 10.1097/IJG.0b013e318294869b10.1097/IJG.0b013e318294869b ↗
17. 10.1016/j.jconrel.2015.10.02710.1016/j.jconrel.2015.10.027 ↗
18. 10.1167/tvst.4.3.410.1167/tvst.4.3.4 ↗
19. Hernández-Montelongo J. · Int. J. Electrochem Sci. · 2012 · 7 · 184010.1016/S1452-3981(23)13844-2 ↗
20. 10.3390/s9060463510.3390/s90604635 ↗
21. 10.1021/acsami.7b0907110.1021/acsami.7b09071 ↗
22. 10.1186/1556-276X-7-38510.1186/1556-276X-7-385 ↗
23. 10.1016/j.biomaterials.2010.11.01310.1016/j.biomaterials.2010.11.013 ↗
24. 10.1167/iovs.14-1599710.1167/iovs.14-15997 ↗
25. 10.1021/acsami.8b0627510.1021/acsami.8b06275 ↗
26. 10.1016/j.solmat.2013.07.00310.1016/j.solmat.2013.07.003 ↗
27. 10.1007/s11595-017-1629-310.1007/s11595-017-1629-3 ↗
28. 10.1016/j.apcata.2013.03.03510.1016/j.apcata.2013.03.035 ↗
29. 10.1021/acsami.7b0639310.1021/acsami.7b06393 ↗
30. 10.1016/j.msec.2016.04.07710.1016/j.msec.2016.04.077 ↗
31. 10.1167/iovs.15-1748010.1167/iovs.15-17480 ↗
32. 10.1016/j.ophtha.2012.10.01510.1016/j.ophtha.2012.10.015 ↗
33. 10.1038/s41598-017-04008-w10.1038/s41598-017-04008-w ↗
34. 10.1016/j.intimp.2016.05.01810.1016/j.intimp.2016.05.018 ↗
35. 10.1177/11206721050150010510.1177/112067210501500105 ↗
36. 10.1016/j.ophtha.2003.09.03710.1016/j.ophtha.2003.09.037 ↗
37. 10.1016/j.ophtha.2017.08.02810.1016/j.ophtha.2017.08.028 ↗
38. 10.1001/archopht.120.3.29710.1001/archopht.120.3.297 ↗
39. 10.1016/S0002-9394(14)71349-210.1016/S0002-9394(14)71349-2 ↗
40. Cordeiro M. F. · Invest. Ophthalmol. Vis. Sci. · 1997 · 38 · 1639
41. 10.1186/1471-2415-14-10710.1186/1471-2415-14-107 ↗
42. 10.1021/cm040149010.1021/cm0401490 ↗
43. 10.1016/j.micromeso.2008.07.00210.1016/j.micromeso.2008.07.002 ↗
44. 10.1016/j.fct.2007.04.00110.1016/j.fct.2007.04.001 ↗
45. 10.1186/1743-8977-7-3910.1186/1743-8977-7-39 ↗
46. 10.1002/jat.138210.1002/jat.1382 ↗
47. 10.1021/nn103077k10.1021/nn103077k ↗
48. Godin B. · Controll Release Newsl. · 2008 · 25 · 9
49. 10.1016/S0142-9612(01)00170-310.1016/S0142-9612(01)00170-3 ↗
50. 10.1016/S0168-3659(01)00248-610.1016/S0168-3659(01)00248-6 ↗
51. Collignon N. J. · Bull. Soc. Belge Ophtalmol. · 2005 · 55
52. 10.1167/iovs.04-061010.1167/iovs.04-0610 ↗
53. 10.1136/bjo.2006.10032110.1136/bjo.2006.100321 ↗
54. 10.1167/iovs.12-1131010.1167/iovs.12-11310 ↗
55. Park K. H. · Ophthalmic Surgery and Lasers · 1996 · 27 · 45210.3928/1542-8877-19960601-10 ↗
56. 10.1080/0271368090296316710.1080/02713680902963167 ↗
57. 10.1111/j.1349-7006.2005.00103.x10.1111/j.1349-7006.2005.00103.x ↗
58. 10.1172/JCI11938210.1172/JCI119382 ↗
59. 10.1039/C7CS00219J10.1039/C7CS00219J ↗